UH Seidman Cancer Center

Refer to the Brain Tumor and Neuro-Oncology Center

HOSPITAL
University Hospitals Seidman Cancer Center

APPOINTMENT LINE
Please call 216-844-6054, option 3.
For hospital transfers, please call 216-844-1111


OUR TEAM

Andrew E. Sloan, MD, FACS
Professor & Vice Chairman, Department of Neurosurgery
Peter D. Cristal Chair of Neurosurgical Oncology
Director, Brain Tumor & Neuro-Oncology Center
Director, Center of Excellence, Translational Neuro-Oncology

Rob Buerki, MD, MPhil
Assistant Professor of Neurology
Director of Medical Neuro-Oncology

Brian Bonder, MD
Assistant Professor of Medical Oncology

Serah Choi, MD
Assistant Professor of Radiation Oncology
Director of Brain & Spine Radiosurgery

Alia Hdeib, MD
Assistant Professor of Neurosurgery
Director of Spinal Metastasis Program

Tiffany Hodges, MD
Assistant Professor of Neurosurgery

Conditions Treated

  • Primary brain tumors: Glioblastoma multiforme (GBM) , astrocytoma, ollgodendroglioma, ependymoma, hemangioblastoma, meningioma, schwanoma, pituitary adenoma, medulloblastoma, pilocytic astrocytoma, ganglioglioma, pleomorphic xanthrocytoma (PXA)
  • Pineal neoplasms
  • Skull base tumors (chordoma, chondrosarcoma)
  • Metastatic brain tumors
  • Leptomeningeal metastasis
  • Spine tumors (primary and metastatic)
  • Peripheral nerves tumors
  • Neurofibromatosis
  • Radiation necrosis of the brain

Therapies

  • Image-guided (stereotactic) surgery
  • Skull base surgery
  • Minimally invasive techniques (keyhole surgery)
  • Laser interstitial thermotherapy (LITT) and stereotactic laser ablation (SLA)
  • Stereotactic radiosurgery: Gamma Knife® radiosurgery for brain tumorss
  • Proton therapy
  • Convection enhanced delivery
  • Chemotherapy
  • Radiotherapy
  • Immunotherapy
  • Stem cell therapies
  • Cell-based therapies
  • Gene therapy
  • Antiangiogenic therapy
  • Hyperbaric oxygen for radiation necrosis

Distinguishing Features

  • Part of NCI-designated Case Comprehensive Cancer Center
  • Multidisciplinary consultation with disease-specific tumor boards
  • Personalized therapies incorporating genetic and genomic analysis and genomic tumor board
  • National leadership in clinical trials: Adult Brain Tumor Consortium (ABTC) and NRG
  • 3T intraoperative MRI (iMRI) and Surgical Theater Rehearsal Platform for patient-specific surgical rehearsal
  • Advanced imaging including MRI, MRA, PET-MRI and MR fingerprinting
  • Genetic risk assessment to guide preventive strategies in cancer-prone families
  • Validated nomograms for patient-specific prognosis
  • Supportive and Integrative Oncology and Adolescent and Young Adult (AYA) cancer programs
Back to Top